DBVT DBV Technologies S.A. ADRs

DBV Technologies SA is a biopharmaceutical company. It is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:DBV.

$6.43  +0.54 (9.17%)
As of 04/14/2021 15:59:30 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  France
IPO date:  10/22/2014
Outstanding shares:  109,873,374
Average volume:  110,189
Market cap:   $647,154,173
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    23306J101
ISIN:        US23306J1016
Sedol:      BRS66Y4
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   3.14
PS ratio:   206.79
Return on equity:   -57.04%
Net income %:   -3,745.28%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy